# Population Pharmacokinetics of Antiretroviral in Children

> **NCT03194165** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 65 (actual)

## Conditions studied

- Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed

## Interventions

- **BIOLOGICAL:** Dolutegravir
- **BIOLOGICAL:** Raltegravir
- **BIOLOGICAL:** Rilpivirine
- **BIOLOGICAL:** Nevirapine
- **BIOLOGICAL:** Atazanavir
- **BIOLOGICAL:** Darunavir
- **BIOLOGICAL:** Ritonavir

## Key facts

- **NCT ID:** NCT03194165
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-16
- **Primary completion:** 2022-06-16
- **Final completion:** 2022-06-16
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2026-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03194165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03194165, "Population Pharmacokinetics of Antiretroviral in Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03194165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*